[Weight change, cardiometabolic risk and the impact of antidiabetic medications in type 2 diabetic patients]. / Variations pondérales, risque cardiométabolique et impact des médicaments antidiabétiques chez le diabétique de type 2.
Ann Cardiol Angeiol (Paris)
; 59(4): 214-20, 2010 Aug.
Article
em Fr
| MEDLINE
| ID: mdl-20691966
In the first part of this review article, the prognostic impact of weight and weight changes in terms of clinical outcomes and metabolic control is reviewed, through the analysis of the results of several large cohorts and prospective studies of diabetic patients followed in "real world" settings. The second part of the review focuses on the impact of antidiabetic medications on weight, emphasising the importance of a comprehensive approach, taking into account weight, in the management of diabetic patients.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Peso Corporal
/
Doenças Cardiovasculares
/
Síndrome Metabólica
/
Diabetes Mellitus Tipo 2
/
Hipoglicemiantes
/
Obesidade
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Fr
Revista:
Ann Cardiol Angeiol (Paris)
Ano de publicação:
2010
Tipo de documento:
Article